Investment in Associate Company |
6 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 | |||||||||||||||||||||||||||||||||||||
| Investment in Associate Company [Abstract] | |||||||||||||||||||||||||||||||||||||
| INVESTMENT IN ASSOCIATE COMPANY | NOTE 7 – INVESTMENT IN ASSOCIATE COMPANY
As of June 30, 2026 and December 31, 2025, investment in associate company consisted of the following:
Investment in an associate company that the Company has significant influence but does not have control over the investee are accounted for under the equity method. The Company periodically reviews the investment for impairment. The initial measurement and periodic subsequent adjustments of the investment are calculated by applying the ownership percentage to the net assets or equity of the partially owned entity under ASC323. The Company has conducted an impairment test on this long-term equity investment in accordance with ASC323 and has fully provided for impairment losses. |
||||||||||||||||||||||||||||||||||||